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Introduction
Typhoid fever is an acute and sometimes life-threatening 
systemic febrile illness caused by Salmonella enterica serovar 
Typhi (S. typhi) and S. enterica serovar paratyphi (S. paratyphi) 
A, B or C. Although the disease caused by S. paratyphi has 
traditionally been thought to run a more benign course1,2, 
recent observations have indicated that S. paratyphi has an 
almost identical clinical syndrome to S. typhi3.Typhoid is 
transmitted by water and food which are contaminated by 
faeces; human beings are the only known reservoir. Typhoid 
remains a global public health problem with a higher burden 
in low- and middle-income countries (LMICs) due to poverty, 
limited access to safe water and unhygienic practices4. In 
2000, there were 21.6 million new cases of  typhoid fever, 
210,000 typhoid fever-related deaths and 5.4 million cases of  
paratyphoid fever5. In 2010, Buckle et al. estimated that there 
were 13.9–26.9 million cases of  typhoid fever worldwide6. 
Without effective treatment, typhoid fever is associated 
with a case-fatality rate of  10–30%, although this reduces to 
1–4% in those receiving appropriate therapy5. Only a limited 
amount of  data are available for the burden created by typhoid 
in several LMICs. Consequently, there is growing interest in 
carrying out studies of  disease burden created by typhoid 
fever in these settings7–9. The Typhoid Fever Surveillance in 
Africa Program (TSAP) was established by the International 
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Abstract
Background
Over-dependence on clinical presentation and/or the Widal agglutination test for the diagnosis of  typhoid fever in developing 
countries can lead to antibiotic abuse. In Nigeria, the antibiotic resistance of  typhoid organisms is poorly characterized. In this study, 
we determined the prevalence of  culture positivity among patients suspected of  having typhoid fever, evaluated the diagnostic value 
of  the Widal test and the burden created by the multi-drug resistance of  typhoid organisms in South-East Nigeria. 
Methodology
This was a prospective and case-controlled study carried out between 2013 and 2016. We acquired samples of  blood/stool/urine 
cultures, and data relating to the Widal agglutination test and malaria parasites from 810 febrile patients (suspected of  having typhoid) 
and 288 apparently healthy controls. Individuals with a history of  antibiotic use within the previous 14 days were excluded. We then 
carried out antibiotic susceptibility tests on all isolates. Multi-drug resistance was defined as a resistance to ≥3 of  the antibiotics tested. 
We determined the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of  Widal test for typhoid 
laboratory diagnosis compared to bacterial culture which is the gold standard. A P-value <0.05 was considered to be statistically 
significant. 
Results
The mean age of  typhoid suspects was 33.1±6.5 years and 50.7% were women. Of  the 810 typhoid suspects tested, 114 (14.1%) had 
positive cultures for the typhoid organisms Salmonella enterica serovar paratyphi (72) and S. enterica serovar Typhi (42). Sample-specific 
rates of  culture positivity were as follows: stool (72; 8.9%), blood (21; 2.6%) and urine (21; 2.6%), P<0.001. None of  the controls had 
typhoid isolates. The sensitivity, specificity, PPV and NPV of  the Widal test were 49.1%, 90.7%, 46.2% and 91.6%, respectively. Malaria 
parasitaemia was detected in 180 (22.2%) febrile patients, out of  whom 115 (63.9%) had a positive Widal test for O/H antigens vs. 
1% (6/630) in those with negative malaria parasite test results (P<0.001). The rate of  false-positive Widal titres was 48%. Antibiotic 
multi-drug resistance was detected in 52.6% of  patients. The antibiotics with the highest susceptibility were ciprofloxacin, levofloxacin 
and meropenem (all 100% susceptibility) and ceftriaxone (95.6% susceptibility). 
Conclusion
Our data showed that while typhoid fever is common in Nigeria, malaria is more prevalent. Our analysis showed that the Widal test 
performed poorly as a diagnostic test and that the burden created by multi-drug resistance was high. Our data indicate that periodic 
surveillance of  antibiotic susceptibility is critical for optimal typhoid therapy. 
Key Words
Antibiotics, diagnosis, typhoid, malaria, multi-drug resistance, Widal test
© 2019 The College of  Medicine and the Medical Association of  Malawi. This work is licensed under the Creative Commons Attribution 4.0 International License.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
ORIGINAL RESEARCH
Date Received: 19-Oct-2018
Revision Received:  05-Jul-2019
Date Accepted: 09-Jul-2019
Correspondence: Martin E. Ohanu 
(martin.ohanu@unn.edu.ng)
https://dx.doi.org/10.4314/mmj.v31i3.4 
    Ohanu et al; Malawi Medical Journal 31 (3): 184-192 September 2019              Typhoid prevalence and multi-drug resistance   185
https://dx.doi.org/10.4314/mmj.v31i3.4 
Vaccine Institute to acquire comparable incidence data 
on typhoid fever and invasive non-typhoidal Salmonella 
(iNTS) disease in sub-Saharan Africa. This program adopted 
standardized surveillance protocols in a number of  different 
countries, including Burkina Faso, Ethiopia, Ghana, Guinea-
Bissau, Kenya, Madagascar, Senegal, South Africa, Sudan and 
Tanzania7. Each TSAP site carried out case detection using 
standardized methods to isolate and identify aerobic bacteria 
from the bloodstream of  febrile patients. Incidentally, 
despite being one of  the most populous countries in Africa, 
Nigeria is not among the TSAP sentinel countries. Using a 
mixed-effects model, which was fitted to data originating 
from 32 population-based studies of  typhoid incidence 
in 14 countries (including some TSAP sentinel countries), 
Antillon et al. previously estimated that 17.8 million cases of  
typhoid fever occur each year in LMICs. Moreover, Central 
Africa was predicted to experience the highest incidence of  
typhoid, followed by certain countries in Central, South, and 
Southeast Asia8. 
The isolation of  S. typhi from blood or bone marrow is 
considered to represent the gold standard for the diagnosis 
of  typhoid10. Although stools and urine are not sterile sites, 
and but considering blood culture is often unsuccessful, the 
isolation of  S. typhi from urine or stools remains relevant 
in the diagnosis of  typhoid, particularly in individuals with 
compatible clinical features. However, one must consider that 
the culture of  such samples requires laboratory equipment 
and expertise that are not readily available in most primary 
health centres in resource-limited settings11. On the other 
hand, the Widal agglutination test is relatively affordable, 
easy to perform and requires minimal equipment or 
expertise. However, the Widal test has several limitations12–15. 
For example, Widal test cannot distinguish between a 
current infection and a previous infection or vaccination 
against typhoid. Widal test shows cross-reactivity with 
other Salmonella species. Physicians in developing countries 
are often faced with the challenge of  making treatment 
decisions on the basis of  compatible clinical symptoms 
alone or a combination of  clinical symptoms and Widal 
results obtained from a single acute-phase sample16–19. These 
factors lead to high rates of  inaccurate typhoid diagnosis, 
inappropriate antibiotic therapy, considerable antibiotic multi-
drug resistance (MDR) and potentially worse outcomes19. 
Despite the growing concern related to antibiotic MDR in 
the management of  typhoid fever, only a few studies have 
assessed the current burden created by this disease in sub-
Saharan Africa. We determined the prevalence of  typhoid 
fever (as confirmed by culture) among patients presenting 
with acute febrile illness in a major referral hospital in South-
East Nigeria. We also assessed the diagnostic value of  the 
Widal test using single acute-phase samples and determined 




This was a prospective case-controlled study conducted 
at the University of  Nigeria Teaching Hospital (UNTH), 
Ituku/Ozalla, Enugu. The UNTH is the largest referral 
centre in South-East Nigeria. In 2014, the estimated 
population of  Enugu state was 4,139,59820 with a population 
density of  approximately 460 people per square kilometre. 
Furthermore, approximately 47.5% of  households in Enugu 
state have improved sources of  drinking water, while only 
19% have improved sanitary facilities that are not shared by 
more than one family21. 
Study population 
We recruited patients between 1 June 2013 and 31 May 2016 
attending the outpatients clinic at UNTH. We recruited a 
total of  810 consecutive typhoid fever suspects (141 children 
aged <18 years and 669 adults ≥18 years) presenting with 
fever (axillary temperature >37.5°C) and any two of  our 
inclusion criteria (abdominal pain or discomfort, headache, 
constipation or diarrhoea). We focused on body temperature 
in our inclusion criteria (rather than the history of  fever, 
which is largely subjective) in order to make our blood 
culture surveillance more sensitive. During the same period, 
288 apparently healthy individuals (48 children <18 years 
and 240 adults ≥18 years), who were mostly the relatives of  
the patients, were recruited as controls and were matched 
with the patients for age and gender. Individuals who 
had received antibiotics within the previous 14 days were 
excluded; this limited the impact of  prior antibiotic use on 
our culture results. 
Ethical considerations
Ethics approval was obtained from the Health Research 
and Ethics Committee of  the UNTH (Reference 
number: UNTH/CSA/329/VOL.5; Registration number: 
NHREC/05/01/2008B-FWA 00002458-IRB 2323). 
Written (signed) informed consent was obtained from each 
participant before enrolment and confidentiality was assured. 
Sample collection and cultures 
Prior to the administration of  antibiotics, we collected 
blood, urine and stool samples from each of  the 810 typhoid 
suspects for culture. Blood, urine and stool cultures were 
also processed for the 288 controls. Blood cultures were 
performed by aseptically introducing 10 ml of  blood sample 
into brain heart infusion and thioglycolate-containing liquoid 
media, as described previously by Baron and Finegold22. 
Subcultures from positive blood cultures were performed 
using blood agar and storing them as stock until the isolates 
were completely identified as typhoid organisms.
Approximately 1g of  stool sample from each participant was 
suspended in 5 ml of  sterile saline solution and inoculated 
into appropriate types of  bacteriological agar before and 
after enrichment with selenite-F broth. Specimen and 
subcultures of  stools were plated onto MacConkey and 
deoxycholate agars (Oxoid) and incubated for 24-48hours at 
370C. The resultant suspect colony growths were examined 
for Salmonella using standard methods23. 
Fresh colonies are non-lactose fermenting, circular, smooth, 
glossy, and translucent with delicate nature. S typhi ferments 
maltose, glucose and manitol producing acid but no gas. It 
reduces sulphide in triple sugar iron agar to produce a black 
colour. Urease test was performed to rule out Proteus spp 
among others. Suspected isolates were subjected to rigorous 
serological identification to species level after performing 
a preliminary identification with polyvalent Salmonella O 
antiserum (Oxoid). Slide agglutination was first used and 
positive results were confirmed by tube tests23.
For each participant, 10 ml of  urine was centrifuged at 3000 
rpm for 15 minutes and the resulting sediment inoculated 
onto cysteine lactose electrolyte deficient (CLED) agar before 
and after enrichment with selenite-F broth. The resultant 
suspect colony growths were examined for Salmonella by 
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P=0.32). There was a marginally higher proportion of  
females in each of  the two groups. The mean duration of  
febrile illness was 7.6±3.5 days (range: 1–19 days). 
a Age group <20 years. For febrile patients, this includes 
141 children aged between 12 and 17 years and 9 adults 
aged between 18 and 19 years. For the controls, this 
includes 48 children aged between 12 and 17 years and 5 
adults aged between 18 and 19 years.
Data relating to the febrile patients with positive cultures are 
shown in Table 2. Of  the 810 patients tested, 114 (14.1%) 
were bacteriologically positive for typhoid pathogens. None 
of  the controls had typhoid isolates. Of  the 114 patients 
with positive cultures, S. typhi was isolated in 42 (36.8%) 
cases while S. paratyphi A (n=41), B (n=20), and C (n=11) 
strains were isolated from another 72 (63.2%). When data 
for individual samples were analysed in the 810 typhoid 
suspects, the rates of  culture positivity were as follows: stool 
(72; 8.9%), blood (21; 2.6%) and urine (21; 2.6%); there was 
a statistically significant difference in this respect (P<0.001). 
When testing individual samples from patients with positive 
isolates, we found that stool samples yielded predominantly 
S. paratyphi (79.2%), while blood and urine samples yielded 
predominantly S. typhi (35.7% and 25.5%, respectively); these 
differences were statistically significant (P<0.001). Of  the 
21 typhoid suspects with a positive blood culture result, 7 
(33.3%) also had a positive stool culture. Febrile patients with 
a positive culture result were significantly younger (28.4±4.6 
years vs 37.7±8.3 years, P=0.0002) and significantly more 
women had a positive culture result than men (64 [15.6%] vs 
50 [12.5%]; P=0.21). 
The clinical features of  the febrile patients are summarized 
in Table 3. Only anorexia (P=0.02), constipation (P=0.02), 
abdominal pain/discomfort (P<0.001), splenomegaly 
(P<0.001) and relative bradycardia (P<0.001) showed 
statistically significant differences when compared with the 
clinical features of  febrile patients with negative typhoid 
standard methods23. 
During the processing/analysis of  samples, we used relevant 
standard operating procedures (SOPs) of  the Microbiology 
Department such as SOP for specimen collection, 
transportation and processing, SOP for microbiological 
safety practices, SOP for processing of  blood/other sample 
cultures, Culture media quality control SOP and SOP for 
antimicrobial susceptibility testing. All instruments were 
periodically checked and calibrated by hospital biomedical 
engineers.  
Widal agglutination test 
Sera samples from each of  the 810 typhoid suspects and 288 
controls were used to carry out a semi-quantitative Widal 
agglutination test; this was performed using the standard 
tube dilution procedure24 and Salmonella antigen kits 
manufactured by Gamma Biologicals Inc. (Houston, TX, 
USA). In accordance with the manufacturer’s protocol, we 
used an antibody titre of  ≥1:80 for O antigen, and a titre of  
≥1:160 for H antigen, as cut-off  values for positive titres. 
A negative saline control was used for each batch of  Widal 
tests.
Testing for antibiotic susceptibility/resistance 
The pattern of  antibiotic susceptibility and resistance was 
identified for each isolate; tests involved the agar diffusion 
method using Muller-Hinton agar (Oxoid, Basingstoke, UK) 
against ampicillin (10 µg), amoxicillin-clavulanic acid (30 
µg), cefuroxime (30 µg), ceftriaxone (30 µg), ceftazidime (30 
µg), ciprofloxacin (5 µg), ofloxacin (5 µg), levofloxacin (5 
µg), meropenem (10 µg), erythromycin (15 µg), tetracycline 
(30 µg), trimethoprim-sulphamethoxazole (25 µg) and 
chloramphenicol (30 µg). MDR was defined as resistance of  
an isolate to three or more of  the antibiotics tested19.
Malaria parasite test
For each participant, we carried out Giemsa staining on both 
thick and thin blood films for the microscopic identification 
of  malaria parasites. These procedures were carried out in 
accordance with standard protocols described by the World 
Health Organization (WHO)25. 
Data analysis
Data analysis was carried out using Statistical Package for 
Social Sciences (SPSS) version 20 (IBM, Chicago, Illinois, 
United States). Test of  normality for the population sample 
was done using the Kolmogorov–Smirnov’s test. Categorical 
variables are presented as proportions while continuous 
variables are presented as mean ± standard deviation (SD) if  
distributed uniformly. Categorical variables were compared 
using the chi-square test. Mean values were compared 
using the Student’s t-test while non-normally distributed 
continuous data were compared using the Kruskal–Wallis 
test. Sensitivity, specificity, positive predictive value (PPV) 
and negative predictive value (NPV) were calculated for 
Widal cut-off  titres using culture as the gold standard and 
a P-value <0.05 was considered to be statistically significant. 
Results
The socio-demographic characteristics of  the study 
participants are shown in Table 1. The age of  the febrile 
patients ranged from 12 to 59 years while that of  the control 
group ranged from 12 to 60 years. There was no statistically 
significant difference between the mean ages of  the typhoid 
suspects (33.1±6.5 years) and the controls (34.7±3.2; 












































Table 2.   Typhoid culture results of  febrile patients in 
Enugu, Nigeria
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culture results.
The Widal titres for febrile patients with typhoid fever 
(confirmed by culture) and febrile patients without typhoid 
(culture negative) are shown in Tables 4 and 5, respectively. 
Of  the 114 febrile patients with culture-confirmed typhoid 
fever, 63 (55.3%) individuals had positive Widal titres for the 
O antigen while 6 (5.3%) had positive Widal titres for the 
H antigen. Of  the 696 febrile patients with negative culture 
results, 46 (6.6%) and 31 (4.5%) had positive Widal titres for 
O and H antigens, respectively. All 288 of  the apparently 
healthy control subjects had Widal titres ≤1:40 for O antigen; 
only 2 (0.69%) of  these subjects had titres of  ≥1:160 for the 
H antigen (data not shown). 
Of  the 810 febrile patients, a total of  180 (22.2%) had malaria 
parasitaemia, all due to Plasmodium falciparum. Of  these 180 
patients, 115 (63.9%) had a positive Widal test for O/H 
antigens compared with only 1% (6/630) for those with 
negative malaria parasite test results (P<0.001). However, the 
frequency of  positive typhoid culture results among febrile 
patients with malaria parasitaemia was not significantly 
different from that of  febrile patients with a negative malaria 
parasite test (15.6% vs 13.7%, P=0.52). Therefore, 48.3% 
of  the febrile patients with malaria parasitaemia had a false-
positive Widal test. 
PPV, positive predictive value; NPV, negative predictive value.
The sensitivity, specificity, PPV and NPV of  the overall 
positive Widal titre (both antigens) was 49.1%, 90.7%, 46.2% 
Table 3. Clinical features of  patients evaluated for typhoid 














Fever 810 (100.0) 114 (100.0) 696 (100.0) 1.00
Headache 641 (79.1) 87 (76.3) 554 (79.6) 0.42
Anorexia 553 (68.3) 89 (78.1) 464 (66.7) 0.02
Diarrhoea 470 (58.0) 72 (63.2) 398 (57.2) 0.23




432 (53.3) 102 (89.5) 330 (47.4) <0.001
Vomiting 384 (47.4) 62 (54.4) 322 (46.3) 0.12
Pallor 93 (11.5) 11 (9.6) 82 (11.8) 0.51
Jaundice 19 (2.3) 2 (1.8) 17 (2.5) 0.65
Hepatomegaly 125 (15.4) 23 (20.2) 102 (14.7) 0.13
Splenomegaly 45 (5.6) 20 (17.5) 25 (3.6) <0.001
Tachycardia 404 (49.9) 58 (50.9) 346 (49.7) 0.82
Relative bradycardia 23 (2.8) 14 (12.3) 9 (1.3) <0.001




Frequency % (N=114) Frequency % (N=114)
<1:20 15 13.2 30 26.3
1:20 6 5.3 15 13.2
1:40 30 26.3 45 39.5
1:80 15 13.2 18 15.8
1:160 36 31.6 6 5.3
1:320 6 5.3 0 0
1:640 6 5.3 0 0
Total 114 100 114 100
Table 5. Widal titres of  febrile patients who were negative 
for typhoid culture 
Titre O antigen H antigen
Frequency % (N=696) Frequency % (N=696)
<1:20 546 78.4 583 83.8
1:20 60 8.6 33 4.7
1:40 44 6.3 24 3.4
1:80 40 5.7 25 3.6
1:160 6 0.9 28
4.0
1:320 0 0 3 0.4
1:640 0 0 0 0
Total 696 100 696 100
Table 6. Sensitivity, specificity, PPV and NPV of  titres 
for anti-O (≥1:80) and anti-H (≥1:160) Widal tests in the 
diagnosis of  typhoid fever among febrile patients in Enugu, 
Nigeria




Sensitivity 55.3 0.9 49.1
Specificity 93.3 95.5 90.7
PPV 57.7 16.2 46.2
NPV 92.7 86.0 91.6
Table 7. Patterns of  antibiotic sensitivity/resistance in bacterial 
isolates among febrile patients with typhoid fever, as confirmed 
by culture















2 (4.8) 40 (95.2) 5 (6.9) 67 (93.1) 7 (6.1) 107 (93.9)
Amoxicillin-
Clavulanate
10 (23.8) 32 (76.2) 15 (20.8) 57 (79.2) 25 (21.9) 89 (78.1)
Ceftriaxone
41 (97.6) 1 (2.4) 68 (94.4) 4 (5.6) 109 (95.6) 5 (4.4)
Ceftazidime
33 (78.6) 9 (21.4) 55 (76.4) 17 (23.6) 88 (77.2) 26 (22.8)
Cefuroxime
19 (45.2) 23 (54.8) 19 (26.4) 53 (73.6) 38 (33.3) 76 (66.7)
Ciprofloxacin
42 (100.0) 0 (0.0) 72 (100.0) 0 (0.0) 114 (100.0) 0 (0.0)
Ofloxacin
36 (85.7) 6 (14.3) 64 (88.9) 8 (11.1) 100 (87.7) 14 (12.3)
Chloramphenicol
22 (52.4) 20 (47.6) 43 (59.7) 29 (40.3) 65 (57.0) 49 (43.0)
Levofloxacin
42 (100.0) 0 (0.0) 72 (100.0) 0 (0.0) 114 (100.0) 0 (0.0)
Meropenem
42 (100.0) 0 (0.0) 72 (100.0) 0 (0.0) 114 (100.0) 0 (0.0)
Tetracycline
12 (28.6) 30 (71.4) 20 (27.8) 52 (72.2) 32 (28.1) 82 (71.9)
Co-trimoxazole
16 (38.1) 26 (61.9) 22 (30.6) 50 (69.4) 38 (33.3 76 (66.7)
Erythromycin
0 (0.0) 42 (100.0) 0 (0.0) 72 (100.0) 0 (0.0) 114 (100.0)
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and 91.6%, respectively (Table 6). The antibiotic susceptibility 
profile of  the typhoid isolates is presented in Table 7. None of  
the isolates showed resistance to ciprofloxacin, levofloxacin 
or meropenem. There was only low levels of  resistance 
to ceftriaxone (4.4%) and ofloxacin (12.3%). However, 
isolates showed high levels of  resistance to erythromycin 
(100%), ampicillin (93.9%), amoxicillin-clavulanate (78.1%), 
tetracycline (71.9%), cefuroxime (66.7%) and co-trimoxazole 
(66.7%). The patterns of  susceptibility for S. typhi and S. 
paratyphi were comparable and the overall rate of  antibiotic 
resistance to three or more agents was 52.6% (Table 8).
Discussion 
Based on bacteriological evidence, the prevalence of  typhoid 
fever in this study was 14.1%. Previous studies have reported 
comparable prevalence data of  11.3% to 18.7% among 
febrile patients26–28. In one previous study, Maude et al.26 
reported that 11.3% of  a group of  300 febrile adults/children 
in Bangladesh were positive for typhoid, as determined by 
blood culture and polymerase chain reaction (PCR) for S. 
typhi. In another study, involving 1375 febrile patients from 
all age groups in Nepal, Adhikari et al. found that 17.3% had 
typhoid fever based on positive blood culture results for S. 
typhi27 while Ramyil et al. reported a prevalence of  18.7% 
for typhoid fever among adults/children in North-Central 
Nigeria, as diagnosed by stool culture28. In contrast to our 
findings, some previous studies reported a higher typhoid 
prevalence of  22.1% to 55% among febrile patients in various 
settings in Africa and Asia when using blood cultures29–32. 
Other studies in sub-Saharan Africa have reported a lower 
prevalence of  culture-proven typhoid fever, ranging from 
1% to 5%13,19,33–35. Beyond the variable epidemiology of  
typhoid fever across different environments, there are a 
number of  factors that could explain the disparity between 
our present findings and these earlier studies. For example, 
a previous study of  Indian subjects reported a typhoid fever 
prevalence as high as 55%32; however, the participants in this 
study were all children. This was further supported by our 
own observation that typhoid fever tends to be commoner 
among younger individuals; a phenomenon that has also 
been reported by other authors36–38. The distribution of  
gender within the study population may also contribute to the 
observed differences. For example, a number of  studies have 
reported a male dominance among typhoid fever cases27,28,36, 
although Chowta et al. reported female dominance39. We did 
not observe any differences between genders among our 
study population. Sample size could also contribute to the 
disparity in results between our current study and previous 
studies. Interestingly, the sample size of  our study was 3 to 10 
times higher than that of  previous studies reporting a higher 
prevalence of  typhoid. It is possible that the previous use of  
antibiotics by the participants of  previous studies could also 
have affected the prevalence rates. 
The type of  culture could also influence the observed 
prevalence of  typhoid fever. For example, while several of  
the existing studies only carried out blood cultures26,27,29–32, 
Elseed et al. cultured blood, urine and stools35. In other 
studies, Gopalakrishnan et al., Nsutebu et al. Eleazar et 
al. and cultured both blood and stools31,33,40 while Ramyil 
et al. only carried out stool culture28. In a retrospective 
analysis of  130 patients with typhoid fever who presented 
at a tertiary-care hospital in Tokyo between 1975 and 1998, 
positive cultures were most frequently found in blood (81%), 
followed by stool (50%) and urine (2.1%)36. In a study of  
Egyptian patients, Youssef  et al. found that the rate of  
recovery of  S. typhi from blood culture decreased with the 
duration of  symptoms and fell from 72% in the first week, to 
21% of  patients with symptoms in the second week, and to 
7% in patients with symptoms in excess of  15 days41. While 
stools are considered to be less specific than blood for the 
isolation of  pathogens, the performance of  simultaneous 
blood, urine and stool cultures increases the probability of  
detection. This is considered important in the African setting 
where late presentation is common; when patients present 
late it is possible that the blood cultures may not be positive. 
Our analysis showed that S. paratyphi was more common 
than S. typhi and accounted for 63.2% of  the total number 
of  cases with culture-proven typhoid fever. However, S. typhi 
was the more commonly detected pathogen in blood and 
urine samples. Generally, S. typhi remains the main causative 
organism of  typhoid fever and has been more frequently 
isolated by blood culture1,19,27,31,32,34. Nevertheless, there 
is evidence to suggest that the incidence of  typhoid fever 
caused by S. paratyphi may be increasing33,42,43. Furthermore, 
S. paratyphi tends to cause a milder disease than S. typhi and 
this may partly explain the absence of  classical typhoid fever 
complications in our patients. 
The most common clinical features in our patients with 
positive typhoid cultures were fever, abdominal pain/
discomfort, anorexia, headache, diarrhoea, vomiting and 
tachycardia. However, only anorexia, constipation, abdominal 
pain/discomfort, splenomegaly and relative bradycardia 
showed statistically significant differences when compared 
with the clinical features of  febrile patients with negative 
typhoid cultures. In accordance with our observations, fever 
(90–100%)1,27,33,36,39,42, headache (50–98%)1,27,33,42 and anorexia 
(65–90%)1,27,33 were the most consistent findings among 
typhoid fever patients in other settings. Although diarrhoea 
(19–56%)27,33,36,39,42, abdominal pain (11–48%)27,33,39,42 and 
vomiting (20–46%)27,33,42 were commonly reported buy other 
studies, the proportions of  individuals with these symptoms 
were lower than that seen in our current study. 
Though the confirmatory diagnosis of  typhoid fever is by 
the isolation of  S. typhi or S. paratyphi from appropriate 
samples, most developing countries, such as Nigeria, have 
continued to depend on the Widal test, largely due to limited 
laboratory facilities for culture and more modern tests based 
on nucleic acids. In the present study, the overall sensitivity, 
specificity, PPV and NPV of  the Widal test were 49.1%, 
90.7%, 46.2% and 91.6%, respectively. The low sensitivity 
of  the Widal test shows that the test has only low ability to 
correctly identify individuals who actually have typhoid fever 










R3 8 (19.0) 18 (25.0) 26 (22.8)
R4 6 (14.3) 6 (8.3) 12 (10.5)
R5 4 (9.5) 10 (13.9) 14 (12.3)
R6 2 (4.8) 4 (5.6) 6 (5.3)
R7 1 (2.4) 1 (1.4) 2 (1.8)
TOTAL 21 (50.0) 39 (54.2) 60 (52.6)
Table 8. Patterns of  antibiotic multi-drug resistance (MDR) in 
isolates from febrile patients with typhoid fever, as confirmed by 
culture
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The PPV represents the proportion of  patients with a 
disease that are correctly identified. Hence, our findings 
suggest that a positive Widal test would have a low predictive 
value for the presence of  typhoid fever and as such would 
be a poor diagnostic test. Specificity is the probability that a 
truly infected individual will test positive while NPV is the 
probability that those testing negative are truly non-infected. 
Accordingly, our data suggest that a negative Widal test 
may be useful for excluding typhoid fever in the differential 
diagnosis of  acute febrile illness. This may be helpful in 
tropical countries since such regions are associated with a 
plethora of  diseases that can cause acute febrile illness. 
A major challenge in the comparison of  findings across 
different studies is the variable cut-off  titres for a positive 
Widal reaction. In agreement with our findings, Adhikari et 
al. showed that a Widal test performed on acute phase serum 
in febrile patients in an endemic population in Nepal had 
low sensitivity (45.2%) and PPV (34.2%) but high specificity 
(82.3%) and NPV (87.8%)27. Another study, conducted in 
Egypt, indicated that a negative Widal test result would have 
a good predictive value (NPV= 98%) while a positive result 
would have a poor predictive value (PPV=57%)40. The poor 
diagnostic performance of  a single Widal test in endemic 
regions has been demonstrated in other studies13,19,33,34,44. 
In contrast to these observations, two studies carried out 
in endemic settings in India (PPV=91%, NPV=31%) and 
Bangladesh (PPV=81.1%, NPV=31.7%) found that a single 
Widal test was a relevant diagnostic tool for typhoid fever32,45. 
One of  these previous studies found that the cut-off  titre for 
a positive test was 1:80 for both O and H antigens32. Beyond 
this, it is possible that the relatively small sample size of  these 
earlier studies may partly account for their observations. 
Our present study identified malaria parasitaemia in one-fifth 
of  the typhoid suspects, suggesting that malaria is a more 
common cause of  acute febrile illness in our environment. 
A high proportion of  individuals with malaria parasitaemia 
had positive Widal reactions, a phenomenon that has been 
observed in other studies29,33. The co-existence of  malaria 
parasitaemia and culture-proven typhoid fever was only 
seen in 15.6% of  our patients, which showed that 48% of  
the patients with malaria parasitaemia would have been 
misdiagnosed of  typhoid fever if  we had relied on the Widal 
test alone. In a previous study, Enabulele et al. reported a 
co-infection of  typhoid fever and malaria in 20% of  febrile 
Nigerian patients and demonstrated a statistically significant 
association between the severity of  malaria parasitaemia 
and a positive Widal test29. False-positive Widal titres 
among febrile patients with malaria parasitaemia have been 
previously documented and are thought to be due to the 
cross-reactivity of  the antigen46. It is possible that the malaria 
parasite Plasmodium may share similar strong immunogenic 
antigens with the typhoid organism S. typhi. Infection by P. 
falciparum could therefore evoke the production of  antibodies 
against antigens that will cross-react with S. typhi antigens in 
the test kit, thus leading to a false positive result. This theory 
is supported by the strong correlation observed between 
malaria parasite loading and Salmonella antibody titres in 
previous studies29,46. A heightened anamnestic response 
among febrile parasitaemic patients, thus leading to the 
production of  antibodies that can bind strongly to shared 
similar antigens, could also contribute to false positive Widal 
titres in febrile patients with malaria parasitaemia. These 
findings suggest that the indiscriminate use of  the Widal test 
could lead to the over-diagnosis of  typhoid fever and the 
unnecessary use of  antibiotics in patients with malaria. 
The over-prescription of  antibiotics for typhoid fever 
in developing countries with weak antibiotic policies, 
based on clinical suspicion and/or a single Widal test, 
poses a significant risk for the emergence of  antibiotic 
resistance. One of  the earliest studies conducted in South-
West Nigeria (20 years ago) demonstrated high levels of  
resistance (ranging from 51% to 91%) of  typhoid isolates 
to commonly used agents (ampicillin, chloramphenicol, co-
trimoxazole, tetracycline and cefotaxime) but showed 100% 
susceptibility to ciprofloxacin and ofloxacin, which had been 
newly developed at that time47. Another report from North-
Central Nigeria, more than 10 years later, showed evidence 
of  MDR for S. typhi involving both old and new drugs48; 
however, the exact burden of  MDR was not quantified in 
this previous study. Previous studies in Africa also confirmed 
a changing pattern of  antibiotic resistance and MDR in 
typhoid isolates49,50. This highlights the need for a periodic 
update of  the pattern of  antibiotic susceptibility for typhoid 
isolates. 
Our study showed high levels of  resistance (22.8–
100%) for typhoid isolates to several older and relatively 
newer antibiotics. Our patients showed no resistance to 
ciprofloxacin, levofloxacin and meropenem while only 4.4% 
showed resistance to ceftriaxone; 52.6% of  our patients 
showed resistance to three or more antibiotic agents. Our 
findings are in agreement with previous studies from sub-
Saharan Africa which found MDR in 50% and 52% of  typhoid 
isolates in Ethiopia and Ghana, respectively19,51. A large 
population-based study in Kenya found that S. typhi isolates 
had a much higher MDR of  77.8%52. On the other hand, 
Jamil et al. reported MDR in 36% of  typhoid pathogens in 
Pakistan42. In a surveillance study carried out in Asia, Ochiai 
et al. demonstrated considerable geographic variation in the 
proportion of  typhoid isolates that were MDR within the 
same region37, thus making a strong case for local evidence-
based antibiotic guidelines. The wide distribution and 
growing prevalence of  MDR among typhoid isolates has led 
to fluoroquinolones assuming a primary role in the treatment 
of  typhoid fever. However, over time, the widespread use of  
these agents has been associated with reduced susceptibility 
and documented resistance in some populations53,54. Despite 
this growing concern, the findings of  our present study 
suggest that ciprofloxacin, ofloxacin and ceftriaxone can be 
sustained as first-line antibiotic options for typhoid fever in 
our setting. Levofloxacin and carbapenems would be better 
reserved for cases that are resistant to the current first-line 
options. 
To the best of  our knowledge, this is one of  the most recent 
attempts to characterize the burden of  MDR in the typhoid 
pathogens of  Nigeria. A major strength of  our study was the 
large sample size. Our data were also more robust than in 
other studies because we carried out cultures simultaneously 
on blood, stools and urine samples. Another strength is the 
inclusion of  levofloxacin and meropenem; these drugs are 
being increasingly prescribed on an empirical basis, although 
their effectiveness has been rarely assessed in local studies. 
Nevertheless, this study had some limitations which need to 
be considered. First, we were unable to exclude whether our 
patients were carriers of  Salmonella; thus, it is difficult to 
verify whether some febrile patients with stool isolates were 
just carriers. Moreover, stools are not sterile. Consequently, we 
might only be able to refer to these patients as possible cases 
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of  typhoid fever cases despite the bacteriological evidence. 
Although we made efforts to select our control group from 
the relatives of  the cases with typhoid, this proved to be 
difficult. Thus, we had a good number of  controls that were 
not related to the typhoid suspects. In addition, among the 
controls who were relatives of  the typhoid cases, some were 
adults that lived in separate homes from the typhoid cases. 
These demographic differences probably explain why the 
Widal titres in our control group were not higher than in the 
general population. Another limitation of  this study was that 
we were unable to perform Widal titres on samples from 
convalescents. Although some patients had follow-up clinic 
visits (ranging from 1 to 4 weeks after their initial visit), it was 
difficult to get Widal tests performed on these samples from 
convalescent patients. We excluded individuals who reported 
the previous use of  antibiotics. Antibiotic abuse is fairly 
common in developing countries; as such, we were careful 
to limit the impact of  previous antibiotic use on culture 
results. However, we recognize the fact it might not be 
entirely accurate to depend upon patient reports to exclude 
individuals with a history of  recent antibiotic use. Although 
we used measured body temperature as an inclusion criterion 
for fever, rather than a history of  fever, in order to increase 
the sensitivity of  our blood culture surveillance, it is possible 
that this practice could potentially have led to a higher rate of  
culture-positive typhoid suspects in this study. On the other 
hand, it is also possible that we could have missed some 
typhoid cases with body temperatures that were lower than 
our threshold. At the time of  this study, only an adult blood 
culture system was available in our hospital. As a result, we 
were only able to include children who were between 12 and 
17 years of  age. Children less than 12 years were not included 
because we could not acquire a culture medium system with 
a small enough volume for paediatric cases. 
Conclusion
In conclusion, this study found that culture positivity among 
typhoid fever suspects was common. Salmonella enterica serovar 
paratyphi was more commonly isolated than S. enterica serovar 
Typhi. The Widal agglutination test performed poorly as a 
diagnostic test. We also observed that malaria was a more 
common cause of  febrile illness and was associated with a 
high proportion of  false-positive Widal titres. The prevalence 
of  antibiotic MDR was high and predominantly affected 
older drugs and a few of  the newer agents. We suggest that 
ciprofloxacin and ceftriaxone can be sustained as first-line 
antibiotic options for typhoid fever while levofloxacin and 
carbapenems would be better reserved for cases that are 
resistant to the current first-line options. There is a clear 
need for a periodic review of  the antibiotic susceptibility of  
typhoid pathogens. 
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